Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications

Journal of the American College of Cardiology

Volumn 68, Issue 19, 2016, Pages 2107-2117

  Flego, Davide ^a   Liuzzo, Giovanna ^a   Weyand, Cornelia M ^b   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b STANFORD UNIVERSITY   (United States)

Author keywords

outcome; pathogenesis; signaling; treatment

Indexed keywords

CD31 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; T LYMPHOCYTE RECEPTOR;

ACUTE CORONARY SYNDROME; ADAPTIVE IMMUNITY; ATHEROSCLEROTIC PLAQUE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CORONARY ARTERY DISEASE; EFFECTOR CELL; HUMAN; LYMPHOCYTE DIFFERENTIATION; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UNSTABLE ANGINA PECTORIS; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; T LYMPHOCYTE;

ACUTE CORONARY SYNDROME; ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES; HUMANS; T-LYMPHOCYTES;

EID: 84994079466     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.08.036     Document Type: Review

References (57)

1. 1 Crea, F., Liuzzo, G., Pathogenesis of acute coronary syndromes. J Am Coll Cardiol 61 (2013), 1–11.
2. 2 Hansson, G.K., Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005), 1685–1695.
3. 3 Liuzzo, G., Kopecky, S.L., Frye, R.L., et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100 (1999), 2135–2139.
4. 4 Liuzzo, G., Goronzy, J.J., Yang, H., et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101 (2000), 2883–2888.
5. + T cells toward distinct T-helper cell subsets. Immunol Rev 252 (2013), 12–23.
6. 6 Geginat, J., Paroni, M., Facciotti, F., et al. The CD4-centered universe of human T cell subsets. Semin Immunol 25 (2013), 252–262.
7. null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res 81 (2009), 11–19.
8. 8 Liuzzo, G., Montone, R.A., Gabriele, M., et al. Identification of unique adaptive immune system signature in acute coronary syndromes. Int J Cardiol 168 (2013), 564–567.
9. 9 Liuzzo, G., Vallejo, A.N., Kopecky, S.L., et al. Molecular fingerprint of interferon-gamma signaling in unstable angina. Circulation 103 (2001), 1509–1514.
10. 10 Methe, H., Brunner, S., Wiegand, D., et al. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol 45 (2005), 1939–1945.
11. 11 Rainer, T.H., Graham, C.A., Chan, R.W.Y., et al. Early time-dependent dynamic changes of TBET and GATA3 mRNA expressions in patients with acute coronary syndrome. Dis Markers 35 (2013), 419–429.
12. 12 Lu, Y., Li, L., Yan, H., et al. Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome. Int J Cardiol 168 (2013), 5396–5404.
13. 13 Guo, M., Mao, X., Ji, Q., et al. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunol Cell Biol 88 (2010), 555–564.
14. 14 Hansson, G.K., Libby, P., Tabas, I., Inflammation and plaque vulnerability. J Intern Med 278 (2015), 483–493.
15. 15 Nakajima, T., Schulte, S., Warrington, K.J., et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105 (2002), 570–575.
16. null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 50 (2007), 1450–1458.
17. null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J 32 (2011), 1214–1226.
18. null T cells in patients with acute coronary syndrome. Circ Res 110 (2012), 857–869.
19. null T cells resistant to apoptosis in acute coronary syndrome. Circulation 131 (2015), 709–720.
20. null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis. Cell Immunol 1 (2013), 11–19.
21. 21 Liuzzo, G., Trotta, F., Pedicino, D., Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown. Eur Heart J 34 (2013), 556–559.
22. 22 Cirillo, P., Golino, P., Piscione, F., et al. Transcoronary Th-17 lymphocytes and acute coronary syndromes: new evidence from the crime scene?. Int J Cardiol 153 (2011), 215–216.
23. 23 Zheng, Y., Wang, Z., Deng, L., et al. Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome. Clin Immunol 157 (2015), 65–77.
24. 24 Simon, T., Taleb, S., Danchin, N., et al. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur Heart J 34 (2013), 570–577.
25. 25 Foks, A.C., Lichtman, A.H., Kuiper, J., Treating atherosclerosis with regulatory T cells. Arterioscler Thromb Vasc Biol 35 (2014), 280–287.
26. + regulatory T cells in patients with acute coronary syndromes. Eur Heart J 27 (2006), 2530–2537.
27. 27 Han, S.F., Liu, P., Zhang, W., et al. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol 124 (2007), 90–97.
28. 28 Wigren, M., Björkbacka, H., Andersson, L., et al. Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arterioscler Thromb Vasc Biol 32 (2012), 2000–2004.
29. 29 Zhang, W.C., Wang, J., Shu, Y.W., et al. Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome. J Biol Chem 287 (2012), 34157–34166.
30. 30 Caligiuri, G., Nicoletti, A., Poirier, B., et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 109 (2002), 745–753.
31. 31 Sage, P., Tsiantoulas, D., Baker, L., et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice—brief report. Arterioscler Thromb Vasc Biol 32 (2012), 1573–1576.
32. 32 Biasucci, L.M., Liuzzo, G., Ciervo, A., et al. Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation 107 (2003), 3015–3017.
33. 33 Shah, P.K., Chyu, K., Dimayuga, P.C., et al. Vaccine for atherosclerosis. J Am Coll Cardiol 64 (2014), 2779–2791.
34. 34 Pryshchep, S., Sato, K., Goronzy, J.J., et al. T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome. Circ Res 98 (2006), 1168–1176.
35. 35 Pryshchep, S., Goronzy, J.J., Parashar, S., et al. Insufficient deactivation of the protein tyrosine kinase lck amplifies T-cell responsiveness in acute coronary syndrome. Circ Res 106 (2010), 769–778.
36. 36 Flego, D., Severino, A., Trotta, F., et al. Increased PTPN22 expression and defective CREB activation impair regulatory T-cell differentiation in non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol 65 (2015), 1175–1186.
37. 37 Stanford, S.M., Bottini, N., PTPN22: the archetypal non-HLA autoimmunity gene. Nat Rev Rheumatol 10 (2014), 602–611.
38. 38 Marelli-Berg, F.M., Clement, M., Mauro, C., et al. An immunologist's guide to CD31 function in T cells. J Cell Sci 126 (2013), 2343–2352.
39. + T cells in the blood of atherosclerotic mice with plaque thrombosis. Arterioscler Thromb Vasc Biol 25 (2005), 1659–1664.
40. + T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 26 (2006), 618–623.
41. 41 Flego, D., Severino, A., Trotta, F., et al. Altered CD31 expression and activity in helper T cells of acute coronary syndrome patients. Basic Res Cardiol, 109, 2014, 448.
42. + monocyte subset in acute coronary syndromes. Int J Cardiol 197 (2015), 101–104.
43. 43 Klingenberg, R., Lüsher, T.F., Rheumatoid arthritis and coronary atherosclerosis: two cousins engaging in a dangerous liaison. Eur Heart J 36 (2015), 3423–3425.
44. null T cells in patients with acute coronary syndromes. Circulation 10 (2004), 1230–1235.
45. 45 Bryl, E., Vallejo, A.N., Matteson, E.L., et al. Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis. Arthritis Rheum 52 (2005), 2996–3003.
46. 46 Singh, K., Deshpande, P., Pryshchep, S., et al. ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J Immunol 183 (2009), 8258–8267.
47. 47 van Dijk, R.A., Duinisveld, A.J.F., Schaapherder, A.F., et al. A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis. J Am Heart Assoc, 4, 2015, e001403.
48. 48 Alexander, J.H., Lopes, R.D., James, S., et al., APPRAISE-2 Investigators. Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365 (2011), 699–708.
49. 49 Roffi, M., Patrono, C., Collet, J.P., et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 37 (2016), 267–315.
50. 50 Libby, P., Ridker, P.M., Hansson, G.K., Progress and challenges in translating the biology of atherosclerosis. Nature 473 (2011), 317–325.
51. 51 Hartono, C., Muthukumar, T., Suthanthiran, M., Immunosuppressive drug therapy. Cold Spring Harb Perspect Med, 3, 2013, a015487.
52. 52 Seggewiss, R., Loré, K., Greiner, E., et al. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 105 (2005), 2473–2479.
53. 53 Fornasa, G., Clement, M., Groyer, E., et al. A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc Res 94 (2012), 30–37.
54. 54 Stanford, S.M., Krishnamurthy, D., Falk, M.D., et al. Discovery of a novel series of inhibitors of lymphoid tyrosine phosphatase with activity in human T cells. J Med Chem 54 (2011), 1640–1654.
55. 55 Putnam, A.L., Brusko, T.M., Lee, M.R., et al. Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 58 (2009), 652–662.
56. 56 Zhang, L., Ovchinnikova, O., Jönsson, A., et al. The tryptophan metabolite 3-hydroxyanthranilic acid lowers plasma lipids and decreases atherosclerosis in hypercholesterolaemic mice. Eur Heart J 33 (2012), 2025–2034.
57. 57 Phrommintikul, A., Kuanprasert, S., Wongcharoen, W., et al. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J 32 (2011), 1730–1735.